欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
DK/H/0237/004
药品名称
Optipar
活性成分
Paroxetine hydrochloride 30.0 mg
剂型
Film-coated tablet
上市许可持有人
HEXAL A/S Edvard Thomsens Vej 14 2300 København S Denmark
参考成员国 - 产品名称
Denmark (DK)
Optipar
互认成员国 - 产品名称
Germany (DE)
Belgium (BE)
Ireland (IE)
许可日期
2006/06/20
最近更新日期
2024/11/25
药物ATC编码
N06AB05 paroxetine
申请类型
TypeLevel1:
Line Extension
TypeLevel2:
Additional Strength/Form
TypeLevel3:
Generic Art 10.1 and 10.2 Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final Product Information
|
1 3 1 spc_label_pl _ common_spc _ 4916
Date of last change:2024/09/06
Final Product Information
|
1 3 1 spc_label_pl _ common_spc _ 4916_NHL
Date of last change:2024/09/06
Final Product Information
|
1_3_1 spc_label_pl _ common_pl _ 4_734_1__NHL
Date of last change:2024/09/06
Final Product Information
|
1_3_1 spc_label_pl _ common_pl _ 4_734_1__NHL_2
Date of last change:2024/09/06
Final Labelling
|
1_3_1_spc_label_pl_common_outer_4_2C789_final_clean
Date of last change:2024/09/06
Final PL
|
DK_H_0237_1_2_3_4_WS_1537_Paroxetine_FINAL_PIL_cv
Date of last change:2024/09/06
Final SPC
|
DK_H_0237_1_2_3_4_WS_1537_Paroxetine_FINAL_SPC_cv
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase